WINDTREE THERAPEUTICS INC /DE/ Quarterly Nonoperating Income (Expense) in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2015 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$375K, a 340% decline year-over-year.
  • Windtree Therapeutics Inc /De/ Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $14.4M, a 2376% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2023 was $306K, a 59.6% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2022 was $758K.
  • Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2021 was -$343K, a 84.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $14.4M -$375K -$531K -340% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $15M $14.7M +$14.7M +18323% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $306K -$195K +$52K +21.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $254K $265K -$329K -55.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $583K $156K -$49K -23.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $632K $80K -$126K -61.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $758K -$247K -$211K -586% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $969K $594K +$660K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $309K $205K +$564K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$255K $206K +$88K +74.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$343K -$36K +$457K +92.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$800K -$66K +$249K +79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.05M -$359K +$1.25M +77.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.3M $118K -$51K -30.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$2.25M -$493K +$2.33M +82.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$4.58M -$315K -$376K -616% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.2M -$1.61M -$1.67M -2876% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$2.53M $169K +$49K +40.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$2.58M -$2.82M +$1.37M +32.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-03
Q3 2019 -$3.95M $61K +$520K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$4.47M $58K +$74K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$4.55M $120K -$208K -63.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$4.34M -$4.19M -$10.2M -170% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $5.82M -$459K +$190K +29.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-04-03
Q2 2018 $5.63M -$16K +$596K +97.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-03
Q1 2018 $5.04M $328K +$936K Jan 1, 2018 Mar 31, 2018 10-K 2020-04-03
Q4 2017 $4.1M $5.97M +$6.21M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 -$2.1M -$649K -$19K -3.02% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.08M -$612K +$19K +3.01% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.1M -$608K -$426K -234% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.68M -$234K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$630K +$12.6M +95.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$631K +$727K +53.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$182K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q3 2015 -$13.3M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.36M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.